-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
Features of the Luminex platform from InnoModels Biotechnology
Author:
InnoModels
Release time:
2024-09-11
Introduction
InnoModels Biotechnology (Beijing) Co., Ltd. is a high-tech enterprise founded by scientists from Novo Nordisk China R&D Center, Sino-US Champion, and the Institute of Immunology of Shanghai Jiao Tong University. The company focuses on oncology and tumor immuno pharmacodynamics CRO services, translational medicine research services, and individualized medicine, and is committed to providing a new generation of experimental animal models close to the clinic for the research and development of oncology and tumor immunotherapy. One of the key technological highlights is the Luminex platform, which integrates Luminex's advanced bioassay technologies to provide researchers with efficient and accurate multi-assay solutions.
Luminex Platform Features
1. Multiple Detection Capabilities
The core strength of the Luminex platform is its powerful multi-detection capability. By utilizing color-coded microspheres and flow cytometry, the platform is capable of simultaneously detecting multiple cytokines, biomarkers, and other immune response-related proteins, dramatically improving experimental efficiency and data richness. For example, quantitative detection of up to 50 indicators can be accomplished with a sample size of only 25 μL, which is significant in research and clinical applications.

2. High Sensitivity and Specificity
The Luminex platform ensures high sensitivity and specificity based on its advanced technology principles. Even trace amounts of microorganisms or cytokines can be accurately detected, avoiding false positives or missed detections that can occur with traditional detection methods. This high sensitivity and specificity is especially important for preclinical evaluation of tumor immunotherapy, drug screening and assessment.
3. Simple and efficient operation
The Luminex platform is relatively simple to use and requires no special skills or equipment, which greatly reduces the difficulty and cost of operation. At the same time, the platform offers researchers the convenience of rapid testing, with results typically available in just a few hours. In addition, the platform provides a one-stop service from sample processing to data analysis, ensuring an efficient testing process.
4. Wide range of applications
The Luminex platform has a wide range of applications, not only for disease treatment and monitoring in the medical field, but also for environmental protection, food safety and many other fields. In the field of scientific research, the platform can be used in mouse modeling to study the pathogenesis of diseases and evaluate the activity/mechanism of action of drugs; in the field of translational medicine, it can be used in preclinical studies/evaluations of drugs, including pharmacology/efficacy, toxicology/toxicity generation, and safety evaluation.
5. Strong Technical Support
InnoModels Biotechnology has an experienced technical team with rich testing experience and technical support capability, which can provide users with all-round technical support and services. Whether it is experimental design, sample processing or data analysis, the team can provide professional guidance and assistance to ensure that users can fully utilize the advantages of the Luminex platform to achieve high-quality research results.
Conclusion
The Luminex platform of InnoModels Biotechnology has shown great potential and value in scientific research and clinical applications due to its multi-detection capability, high sensitivity and specificity, easy and efficient operation, and wide range of applications. The platform not only provides efficient and accurate bioassay solutions for researchers, but also provides strong technical support for the research and development of tumor and tumor immunotherapy. It is believed that in the future, the Luminex platform will be applied and promoted in more fields, bringing more convenience and protection to people's health and life.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd